Living donor liver transplantation and hepatitis C
β Scribed by Lisa M. Forman; James F. Trotter; Jean Emond
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 48 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20091
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In this retrospective study of hepatitis C virus (HCV)-infected transplant recipients in the 9-center Adult to Adult Living Donor Liver Transplantation Cohort Study, graft and patient survival and the development of advanced fibrosis were compared among 181 living donor liver transplant (LDLT) recip
Hepatitis C virus (HCV) recurs in nearly all patients after liver transplantation. This recurrence is associated with progressive fibrosis and graft loss. It remains unclear whether the natural course of HCV recurrence is altered in patients who undergo living donor liver transplantation (LDLT). We
## No differences between LDLT and DD Shiffman 1 23 USA, single center yes No patients developed cirrhosis on liver biopsy @ 3 years Russo 10 279 USA, UNOS database no 2-year graft survival 72% LDLT and 75% DD Bozorgzadeh 11 35 USA, single center no No difference in HCV recurrence on liver biopsy
The question of possible earlier and more aggressive recurrence of hepatitis C virus (HCV) infection after living donor liver transplantation (LDLT) compared to deceased donor liver transplantation (DDLT) remains unanswered. To address this issue we retrospectively reviewed virological, histological